YTHDF2 and acute myeloid leukemia: Mice with AML displaying reduced YTHDF2 levels have shown extended survival times, while normal mice with decreased YTHDF2 levels showed an increase in hematopoietic stem cells without any discernible effect on their hematopoietic system functionality.